— Know what they know.
Not Investment Advice
Also trades as: ITRMF (OTC) · $vol 0M

ITRM NASDAQ

Iterum Therapeutics plc
1W: -6.4% 1M: -79.9% 3M: -89.3% YTD: -89.3% 1Y: -97.2% 3Y: -96.5% 5Y: -99.8%
$0.03
Last traded 2026-04-06 — delisted
NASDAQ · Healthcare · Biotechnology · $1.6M mcap · 52M float · 31.17% daily turnover · Short 53% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-27M
Net Income
+11.8% YoY
$-20M
Free Cash Flow
+43.6% YoY
94.9%
Gross Margin
-1892.8%
Op. Margin
-2302.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE285.5%
ROA-111.3%
ROIC-104.4%

Valuation

P/E-0.1
P/B-0.2
EV/EBITDA-2.3

Leverage

Debt/Equity-4.57
Current Ratio2.13
Interest Cov.-10.6x

Quality Scores

Piotroski F5/9
Altman Z-23.55
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms